Search by Drug Name or NDC

    NDC 72893-0001-01 EVOMELA 50 mg/10mL Details

    EVOMELA 50 mg/10mL

    EVOMELA is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Acrotech Biopharma Inc. The primary component is MELPHALAN HYDROCHLORIDE.

    Product Information

    NDC 72893-0001
    Product ID 72893-001_4dd3db2d-aa56-4952-bcad-70fa22e8e93c
    Associated GPIs 21101040102115
    GCN Sequence Number 076651
    GCN Sequence Number Description melphalan HCl/betadex sbes VIAL 50 MG INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 42355
    HICL Sequence Number 043793
    HICL Sequence Number Description MELPHALAN HCL/BETADEX SULFOBUTYL ETHER SODIUM
    Brand/Generic Brand
    Proprietary Name EVOMELA
    Proprietary Name Suffix n/a
    Non-Proprietary Name Melphalan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/10mL
    Substance Name MELPHALAN HYDROCHLORIDE
    Labeler Name Acrotech Biopharma Inc
    Pharmaceutical Class Alkylating Activity [MoA], Alkylating Drug [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207155
    Listing Certified Through 2024-12-31

    Package

    NDC 72893-0001-01 (72893000101)

    NDC Package Code 72893-001-01
    Billing NDC 72893000101
    Package 1 VIAL in 1 CARTON (72893-001-01) / 20 mL in 1 VIAL
    Marketing Start Date 2016-03-31
    NDC Exclude Flag N
    Pricing Information N/A